IHS Chemical Week

Regions :: Western Europe :: U.K.

Pfizer makes final offer for AstraZeneca, will walk away if offer not accepted

10:47 PM MDT | May 18, 2014 | Natasha Alperowicz

Pfizer said on Sunday that it has raised its offer for AstraZeneca to £69 billion ($116 billion), and said it would walk away if AstraZeneca does not accept the offer. The improved proposal is final and cannot be increased, Pfizer says. AstraZeneca shareholders would receive, for each AstraZeneca share, 1.747 shares in the combined entity and 2,476 pence in cash, representing an indicative value of £55.00. On 2 May, AstraZeneca rejected Pfizer's sweetened proposal.   Pfizer says this is an increase of approximately 15% over its 2 May proposal...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa